Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
US8007794B2 · kind B2 · utility
50Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2006 |
| Grant date | Aug 30, 2011 |
| Priority date | — |
| Expiry date | Jun 9, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.